↓ Skip to main content

American Association for Cancer Research

Article Metrics

Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence

Overview of attention for article published in Molecular Cancer Therapeutics, December 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

twitter
84 tweeters

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
36 Mendeley